{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-035238","form_type":"8-K","ticker":"MTVA","cik":"0001638287","company_name":"MetaVia Inc.","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.716168+00:00","generated_at":"2026-05-15T08:50:28.258007+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"MetaVia posts updated corporate presentation on IR website; full content not in excerpt","bullets":["Updated corporate presentation posted to MetaVia's IR website on March 26, 2026.","Presentation highlights company's strategy for transforming cardiometabolic diseases.","No financial, clinical, or pipeline details available from the provided excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-035238","json":"https://secwatch.observer/filing/0001104659-26-035238.json","markdown":"https://secwatch.observer/filing/0001104659-26-035238.md","text":"https://secwatch.observer/filing/0001104659-26-035238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638287/000110465926035238/0001104659-26-035238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638287/000110465926035238/mtva-20260326x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:50:28.258007+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}